Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, $0.001 par value per share · CUSIP: 252828108

Event date: 2024-12-31

Filing-level shares
2,689,707
Percent of class
8.8%
  • BCLS Fund III Investments, LP

    Shares: 2,689,707 · Class: 8.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-020416
Form type
SCHEDULE 13G/A
Filer
BCLS Fund III Investments, LP
CIK
CIK 1952107
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub